{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:09:21Z","timestamp":1777003761603,"version":"3.51.4"},"reference-count":32,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,7,17]],"date-time":"2007-07-17T00:00:00Z","timestamp":1184630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p><jats:list list-type=\"explicit-label\"><jats:list-item><jats:p>Although the systemic and cardiac renin\u2013angiotensin systems are known to be activated in the setting of pressure overload, the actions and signalling mechanisms of angiotensin (Ang) II via AT<jats:sub>1<\/jats:sub>and AT<jats:sub>2<\/jats:sub>receptors in hypertrophic cardiomyocytes (CM) remain largely unclear.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Hypertrophic CM were prepared from rats with aortic banding for 8 weeks, cultured and then treated as follows: (i) 1\u00a0\u00b5mol\/L AngII for 24\u00a0h; (ii) 10\u00a0\u00b5mol\/L losartan (an AT<jats:sub>1<\/jats:sub>receptor antagonist) for 1\u00a0h followed by 1\u00a0\u00b5mol\/L AngII for 24\u00a0h; and (iii) 10\u00a0\u00b5mol\/L PD123319 (an AT<jats:sub>2<\/jats:sub>receptor antagonist) for 1\u00a0h followed by 1\u00a0\u00b5mol\/L AngII for 24\u00a0h. Changes in the expression of genes following stimulation of AT<jats:sub>1<\/jats:sub>and AT<jats:sub>2<\/jats:sub>receptors specific to G\u2010protein\u2010coupled receptor (GPCR) signalling pathways were tested using GEArray (Superarray, Bethesda, MD, USA). The effects of AngII, acting via AT<jats:sub>1<\/jats:sub>and AT<jats:sub>2<\/jats:sub>receptors, on the expression of tumour necrosis factor (TNF)\u2010\u03b1, interleukin (IL)\u20101\u03b2 and IL\u20106 were confirmed by reverse transcription\u2013polymerase chain reaction and radioimmunoassay.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>The genes regulated via stimulation of AT<jats:sub>1<\/jats:sub>receptors were mainly restricted to the signalling pathways including cAMP\/protein kinase (PK) A, Ca<jats:sup>2+<\/jats:sup>, PKC, protein tyrosine kinase, mitogen\u2010activated protein kinases, phosphatidylinositol 3\u2010kinase and nuclear factor\u2010\u03baB. In addition to these pathways related to activation of AT<jats:sub>1<\/jats:sub>receptors, four additional signalling pathways were found to be associated with stimulation of AT<jats:sub>2<\/jats:sub>receptors, including phospholipase C, nitric oxide\/cGMP, Rho and Janus kinase\/signal transducer and activator of transcription. Blockade of AT<jats:sub>2<\/jats:sub>receptors decreased the mRNA and protein expression of TNF\u2010\u03b1 and IL\u20101\u03b2, whereas blockade of AT<jats:sub>1<\/jats:sub>receptors had no such effect.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>In conclusion, in hypertrophic CM, AngII leads to distinct signalling responses mediated by AT<jats:sub>1<\/jats:sub>and AT<jats:sub>2<\/jats:sub>receptors. Stimulation of AT<jats:sub>2<\/jats:sub>receptors appears to have a greater influence on GPCR\u2010signalling than stimulation of AT<jats:sub>1<\/jats:sub>receptors. Angiotensin II enhances the synthesis and secretion of TNF\u2010\u03b1 and IL\u20101\u03b2 in hypertrophic CM, which is mediated by AT<jats:sub>2<\/jats:sub>, but not AT<jats:sub>1<\/jats:sub>, receptors.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p>","DOI":"10.1111\/j.1440-1681.2007.04694.x","type":"journal-article","created":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T05:29:50Z","timestamp":1184736590000},"page":"1191-1198","source":"Crossref","is-referenced-by-count":16,"title":["ANGIOTENSIN II RECEPTORS SUBTYPES MEDIATE DIVERSE GENE EXPRESSION PROFILE IN ADULT HYPERTROPHIC CARDIOMYOCYTES"],"prefix":"10.1111","volume":"34","author":[{"given":"Juan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan\u2010Xi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang\u2010Dao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,17]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"S30","article-title":"Angiotensin II receptors","volume":"10","author":"Ardaillou R.","year":"1999","journal-title":"J. Am. Soc. Nephrol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/08037050310001057"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200109000-00022"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00145-5"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.73.3.439"},{"key":"e_1_2_6_7_2","first-page":"H844","article-title":"Distribution and function of cardiac angiotensin AT1\u2010 and AT2\u2010receptor subtypes in hypertrophied rat hearts","volume":"267","author":"Lopez JJ","year":"1994","journal-title":"Am. J. Physiol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118346"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.1998.073bx.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00755"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M507460200"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(01)01735-8"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2003.03942.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114924"},{"key":"e_1_2_6_15_2","first-page":"H1791","article-title":"Identification and activation of autocrine renin\u2013angiotensin system in adult ventricular myocytes","volume":"269","author":"Zhang X","year":"1995","journal-title":"Am. J. Physiol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/hh0901.089882"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II\u2010mediated cardiovascular and renal diseases","volume":"52","author":"Kim S","year":"2000","journal-title":"Pharmacol. Rev"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.24.385"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2005.01.005"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi265"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704103361506"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2004.02.005"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00594-X"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000130564.75008.F5"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.86.12.1266"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.12.003"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200109000-00022"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.283"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00728.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.05.040"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/hh0202.104109"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-0214"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2001.1433"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2007.04694.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2007.04694.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T15:47:18Z","timestamp":1737301638000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2007.04694.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,17]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1111\/j.1440-1681.2007.04694.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2007.04694.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,17]]}}}